Ally Bridge Group (Ny) LLC Context Therapeutics Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $88.1 Million
- Q4 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 1,576,762 shares of CNTX stock, worth $1.28 Million. This represents 1.77% of its overall portfolio holdings.
Number of Shares
1,576,762
Previous 1,757,524
10.29%
Holding current value
$1.28 Million
Previous $3.44 Million
54.7%
% of portfolio
1.77%
Previous 2.45%
Shares
5 transactions
Others Institutions Holding CNTX
# of Institutions
55Shares Held
72.9MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$11.9 Million2.18% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$6.06 Million0.84% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$6.01 Million0.32% of portfolio
-
Nextech Invest Ag7.42MShares$6.01 Million1.37% of portfolio
-
Blue Owl Capital Holdings LP New York, NY6.36MShares$5.15 Million2.69% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $12.9M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...